


@article{Kwon2020PostDonationDonors,
    author = {Kwon, So-Yong and Kim, Eun-Jin and Jung, Yu Soek and Jang, Jin Sung and Cho, Nam-Sun},
    title = {Post-donation COVID-19 identification in blood donors.},
    journal = {Vox Sang},
    issn = {},
    year = {2020},
    volume = {},
    number = {},
    pages = {},
    doi = {10.1111/vox.12925}
    citedbycount = {0},
    abstract = {The coronavirus disease 19 (COVID-19) outbreak, which was characterized as a pandemic on 11 March 2020 by the WHO, started in December 2019 with the emergence of pneumonia cases of unknown cause in Wuhan, Hubei, China [1]. SARS-CoV-2, the causative agent of COVID-19, are enveloped, non-segmented, single stranded positive sense RNA viruses and are classified as a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-Co. Vs) of the species Severe acute respiratory syndrome-related coronavirus [2]. So far, no respiratory virus, including SARS-CoV and the Middle East Respiratory Syndrome (MERS)-CoV, has been confirmed as transfusion-transmissible [3,4].},
    keywords = {severe acute, syndrome coronavirus, causative agent, respiratory syndrome, acute respiratory}
}
